---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-23-000080"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2023-08-01T23:59:59+00:00"
generated_at: "2026-06-12T18:24:18.981933+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q2 revenue $667.6M (+8.5% YoY), EBITDA beat; FY guidance raised

## Summary
- Revenue $667.6M (+8.5% YoY); same-facility revenue +8.3% (~10% adj. for $8M cyber headwind).
- Net income $18.9M vs ($18.4M) loss; Adjusted EBITDA $100.2M, +16.4% YoY; margin 15.0%.
- FY 2023 Adjusted EBITDA guidance raised to >$435M; revenue reaffirmed >$2.75B; free cash flow >$140M.
- Combined surgical case volume +5%; non-consolidated minority revenue +30%.
- Deployed ~$60M capital in Q2; new partnership with Methodist Health System in Dallas, TX.

## SEC filing metadata
- accession: 0001638833-23-000080
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2023-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/0001638833-23-000080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/sgry-20230801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-23-000080
- JSON: https://secwatch.observer/filing/0001638833-23-000080.json
- Plain text: https://secwatch.observer/filing/0001638833-23-000080.txt

## Key facts
- Earnings Releases
  Surgery Partners, Inc. reported for fiscal year 2023 results: revenue greater than $2.75 billion. Guidance raised.
  - Period: for fiscal year 2023
  - Revenue: greater than $2.75 billion
  - Guidance: raised
  - Result: guidance update
  source text: Full year Adjusted EBITDA guidance raised to greater than $435 million, revenue reaffirmed at greater than $2.75 billion, inclusive of the cyber event, and free cash flow reaffirmed at greater than $140 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/0001638833-23-000080-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported for the second quarter ended June 30, 2023 results: revenue Revenues were $667.6 million, net income Net income attributable to Surgery Partners was $18.9 million.
  - Period: for the second quarter ended June 30, 2023
  - Revenue: Revenues were $667.6 million
  - Net income: Net income attributable to Surgery Partners was $18.9 million
  - Result: reported results
  source text: Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023. • Revenues were $667.6 million representing 8.5% growth and are inclusive of an $8 million cyber event headwind • Same-facility revenues increased 8.3% on an unadjusted basis and approximately 10% adjusting for the cyber event • Non-consolidated minority interest revenue increased by over 30% • Net income attributable to Surgery Partners was $18.9 million • Adjusted EBITDA was $100.2 million, representing 16.4% growth • Adjusted EBITDA margin improved by over 100 basis points year-over-year to 15.0% • Combined, consolidated and unconsolidated surgical case volume grew 5%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/0001638833-23-000080-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.